Article Details
Retrieved on: 2022-02-13 06:10:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Renaissance Technologies LLC now owns 223,870 shares of the biopharmaceutical company's stock valued at $1,475,000 after buying an additional 97,375 ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here